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The presence of intense infiltration of TAMs in the tumor 
stroma was related to shorter DFS (p = 0.005) and OS 
(p = 0.006). The opposite tendency was observed in the 
tumor front (p = 0.061). The relative risks of recurrence 
and cancer-related death were more than twice higher in 
the group of patients with intense infiltration of TAMs in 
the tumor stroma (RR 2.05, 95% CI 1.33–3.14; p = 0.001 
and RR 2.08, 95% CI 1.28–3.39; p = 0.003, respectively). 
Intense infiltration of Tregs in the tumor stroma was related 
to shorter DFS and OS (p < 0.0001). The relative risks of 
recurrence and death in a group of patients with intense 
infiltration of Tregs in the tumor stroma were more than 12 
times higher than in patients with less intense infiltration 
(RR 12.3, 95% CI 5.44–27.9; p < 0.0001 and RR 12.5, 95% 
CI 4.9–32.4; p < 0.0001, respectively). Infiltration of TAMs 
 CD68+/iNOS− and Tregs  CD8+/FoxP3+ in the tumor 
stroma are negative prognostic factors with a positive cor-
relation between them. Tregs may constitute an independ-
ent prognostic factor in patients with CRC.
Keywords Tumor-associated macrophages · TAMs · 
Tregs · Regulatory lymphocytes · Colorectal cancer
Introduction
Colorectal cancer (CRC) is one of the most common types 
of cancer and it constitutes one of the main causes of death. 
This form of cancer is the third most common cancer in 
the world, with nearly 1.4 million new cases diagnosed in 
2012 (Ferlay J et al. 2014). The pathogenesis of CRC in the 
aspect of the tumor microenvironment is understood as a 
complex model of mutual relationships and a complex of 
interactions between developing cancer and the surround-
ing tissue, including the immune system (Muc-Wierzgoń 
Abstract The aim of the study is the assessment of 
the intensity of the infiltration of tumor-associated mac-
rophages (TAMs)  CD68+/iNOS− and Tregs  CD8+/FoxP3+ 
in colorectal cancer (CRC) patients as prognostic fac-
tors with respect to disease-free survival (DFS) and over-
all survival (OS). In this retrospective study, tissue sam-
ples were obtained from 89 patients undergoing resection 
for CRC (stage IIA, pT3N0M0 and stages IIIB and IIIC, 
pT3N1-2M0). Recurrence was observed in 45 patients at 
the time of the follow-up (10 local recurrences, 35 distant 
metastases). In patients with recurrence the following were 
present: a tendency to an older average age at the time of 
diagnosis (p = 0.07), higher nodal involvement (p = 0.002) 
and more advanced clinical disease (p = 0.01). The analy-
sis of the clinical data and immunohistochemical studies 
were performed with the methodology of identification of 
TAM and Treg subsets in histological sections, with the 
aim to use it in routine clinical management. Both DSF 
and OS were the clinical parameters assessed in the study. 
 * Małgorzata Muc-Wierzgoń 
 mwierzgon@sum.edu.pl
1 SHS in Katowice, Department of Propaedeutics Surgery, 
Chair of General, Colorectal and Polytrauma Surgery, 
Medical University of Silesia in Katowice, Żeromskiego 7, 
41-902 Bytom, Poland
2 SHS in Katowice, Chair of General, Colorectal 
and Polytrauma Surgery, Medical University of Silesia 
in Katowice, Plac Medyków 1, 41-200 Sosnowiec, Poland
3 Tumor Pathology Department, Maria Sklodowska-Curie 
Memorial Cancer Center and Institute of Oncology, Gliwice 
Branch, Armii Krajowej 15, 44-100 Gliwice, Poland
4 Department of Internal Medicine, Medical University 
of Silesia in Katowice, Żeromskiego 7, 41-902 Bytom, 
Poland
 Arch. Immunol. Ther. Exp.
1 3
et al. 2014; Piktel et al. 2016). At present, it is confirmed 
that the type, the location and the density of immune cells 
infiltrating the tumor are the manifestations of the immune 
response within the tumor environment. Both mechanisms 
of innate and acquired immunity play a significant role in 
tumor development and progression. Consequently, they 
influence the course of disease (Ohtani 2007; Pages et  al. 
2005). Tumor-associated macrophages (TAMs) are a com-
ponent of the innate immunity, whereas subpopulations of 
regulatory T-lymphocytes (Tregs) are a part of the acquired 
immunity. Changes in the number of subpopulations of 
TAMs and Tregs and various relationships between them 
are observed in CRC patients. It seems that within the 
tumor microenvironment TAMs polarize toward tumor-
promoting phenotypes. By activation of direct and indi-
rect mechanisms due to the inability to present antigen, 
TAMs predominantly represented in the tumor by the M2 
phenotype induce the creation of lymphocytes showing 
the expression of the forkhead box P3 transcription factor 
 (FoxP3+). These lymphocytes are responsible for immune 
tolerance of the system to the tumor (Gabrilovich et  al. 
2012; Galon et al. 2006; Ramanathan et al. 2008; Shih et al. 
2006). This mechanism may create favorable conditions for 
tumor development and it promotes further neoplastic pro-
gression (Zou 2006). However, in the case of CRC, which 
is largely inflammation-dependent tumor, these relation-
ships are considerably more complex and more difficult to 
predict. The authors made an attempt to use the quantitative 
and phenotypic assessments of the previously mentioned 
components of the immune system as additional prognostic 
factors in patients in whom commonly used prognostic fac-
tors fail for a number of reasons.
The aim of the study was the assessment of the inten-
sity of M2 macrophage infiltration defined as  CD68+/
iNOS− and the intensity of  CD8+/FoxP3+ lymphocyte infil-
tration as prognostic factors for disease-free survival (DFS) 
and overall survival (OS) in patients who underwent surgi-
cal treatment due to CRC.
Materials and Methods
Study Groups
Eighty-nine patients who were primarily operated on due 
to CRC between 2008 and 2011–stage IIA (pT3N0M0) 
and stages IIIB and IIIC (pT3N1-2M0) were enrolled in 
this retrospective study. The enrollment was performed in 
a manner providing a similar number of patients with con-
firmed recurrence and without symptoms of recurrence 
during the follow-up. The exclusion criteria were as fol-
lows: patients >80  years of age, young patients in whom 
genetic background of the disease had been confirmed 
(familial adenomatous polyposis and hereditary nonpoly-
posis CRC), patients treated due to autoimmune and rheu-
matoid diseases. Patients with oncological history due to 
another type of tumor were also excluded from the study.
The clinical parameters analysed in the present study 
included DFS which was defined as the time from surgery 
to the occurrence of local relapse or distant metastases 
and OS. The results of immunohistochemical staining as 
well as complete clinical data on disease progression and 
the postoperative course were obtained for all of the ana-
lyzed cases. Recurrence at the follow-up was observed in 
45 patients. Ten of 45 patients presented with local recur-
rence or recurrence in the abdominal wall. In the remain-
ing 35 patients, distant metastases were observed, mainly to 
the liver (29 cases) and to the lungs (6 cases). A tendency 
to an older average age at the time of diagnosis (p = 0.07) 
as well as higher nodal involvement (p = 0.002) and higher 
clinical progression of the disease (p = 0.01) was observed 
in patients with recurrence. The complete characteristics of 
the study groups are presented in Table 1.
Immunohistochemical Staining
In order to visualize macrophage infiltration within the 
tumor and at the tumor front, we used the CD68 marker 
showing the expression in all macrophage-like cell types 
regardless of their phenotype (both in M1 subtypes and M2 
family). A number of phenotypes were described within 
M2 macrophages. These phenotypes differed in terms of 
the expression of specific markers. To visualize them, a 
simultaneous use of at least several antibodies would be 
necessary. Therefore the authors initially decided to use 
immunohistochemical staining of the M1 macrophages 
with anti-nitric oxide synthase antibody present solely in 
M1 macrophages in order to be subtracted from the over-
all number of all macrophages  CD68+ with the intention 
to simplify the method without influencing its specificity. 
However, during the investigation the authors found only 
very scant infiltration of iNOS positive cells in compari-
son to relatively abundant CD68-positive infiltrates (<1% 
 iNOS+ cells in the pool of  CD68+ cells). Therefore, it was 
decided to treat the total CD68-positive pool as M2 pheno-
type macrophages  CD68+/iNOS− without introducing sig-
nificant bias. The reader of the article should bear in mind 
this assumption in every case where the authors refer to 
 CD68+/iNOS− phenotype.
The transcription factor  FoxP3+, which is considered a 
specific marker of Treg lymphocytes, was detected in the 
overall number of lymphocytes showing the expression of 
 CD8+ surface antigen in order to determine the intensity 
of infiltration of Treg lymphocytes defined in this study as 
demonstrating coexpression of  CD8+/FoxP3+ proteins.
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Tissue samples collected in the form of paraffin blocks 
were used for immunohistochemical studies. Four immu-
nohistochemical stainings were performed from each block 
containing tumor tissues, using the following antibodies: 
monoclonal mouse antibody anti-CD68, clone PG-M1 
(catalogue no.: M 0876; Dako, Denmark), rabbit mono-
clonal anti-FoxP3 antibody—clone SP97 (catalogue no.: 
506-3974; Zytomed Systems, Berlin), mouse monoclonal 
anti-CD8 antibody—clone C8/144B (catalogue no.: IR623; 
Dako, Denmark), rabbit polyclonal anti-iNOS antibody 
(catalogue no.: NB300-605; Novus Biologicals, UK). All 
paraffin-embedded blocks with tumor tissues were cut into 
4-μm sections. Deparaffinization of the samples and tis-
sue antigen retrieval were performed using PT-Link (cata-
logue no.: PT101; Dako, Denmark) and buffers of various 
pH: EnVision Flex Target Retrieval Solution, High pH 
(catalogue no.: K8024; Dako, Denmark) for specimens 
incubated with monoclonal anti-FoxP3, anti-CD8 and anti-
CD68 antibodies and EnVision Flex Target Retrieval Solu-
tion, Low pH (catalogue no.: K8005; Dako, Denmark) for 
specimens stained using polyclonal anti-iNOS antibody. To 
avoid false-positive immunohistochemical reaction, endog-
enous peroxidase activity was blocked with 3% hydrogen 
peroxide for 5 min.
The technical details related to primary antibody dilu-
tions, dilution buffer, incubation time and the type of 
positive control are presented in Table  2, whereas the 
results of staining for positive controls are shown in the 
Fig. 1.
EnVisionTM FLEX/HRP system was used to visu-
alize the antigen-primary antibody reaction (catalogue 
no.: K8024; Dako, Denmark), consisting of a mixture 
of goat anti-mouse and anti-rabbit antibodies linked to 
polymer containing immobilized horseradish peroxidase 
and chromogen 3,3′-diaminobenzidine (EnVisionTM 
FLEX DAB + Chromogen, catalogue no.: K8024; Dako, 
Denmark).
The sections were counterstained using aqueous solution 
of hematoxylin (Mayer’s solution), they were dehydrated 
and closed using a permanent mounting medium (Dako 
Toluene-Free Mounting Medium, catalogue no.: CS705; 
Dako, Denmark).
Evaluation of Immunohistochemical Reactions
The evaluation of immunohistochemical reactions was per-
formed using a light microscope, Olympus (Tokyo, Japan) 
type CX41–5× and 10× magnification objectives for fea-
tures rated using a semi-quantitative scale and 40× for 
quantitative features. The intensity of macrophage infiltra-
tion  CD68+ was determined semi-quantitatively using a 
4-point scale based on the following criteria: 0—negative, 
Table 1  Clinico-pathological characterization of CRC patients enrolled in the study in groups depending on evidence of the recurrence
*Statistically significant differences between groups were observed in the N feature of the TNM classification and clinical staging
Feature Patients with recurrence, n = 45 Patients with no recurrence, n = 44 Statistical significance
Median and age range (years) 65 (40–84) 69 (45–85) p = 0.07





Tumor location Right intestine: 11 (24.4%)
Left intestine: 34 (75.6%) Including: 
caecum: 9 (20.0%)
ascending colon: 1 (2.2%)
hepatic flexure: 1 (2.2%)
transverse colon: 0 (0.0%)
splenic flexure: 1 (2.2%)
descending colon: 2 (4.4%)
sigmoid colon: 9 (20.0%)
sigmoid colon-rectum: 3 (6.7%)
rectum: 19 (42.2%)
Right intestine: 19 (43.2%)
Left intestine: 25 (56.8%) Including: 
caecum: 8 (18.2%)
ascending colon: 7 (15.9%)
hepatic flexure: 3 (6.8%)
transverse colon: 1 (2.3%)
splenic flexure: 1 (2.3%)
descending colon: 4 (9.1%)
sigmoid colon: 11 (25.0%)
sigmoid colon-rectum: 2 (4.5%)
rectum: 7 (15.9%)
p = 0.13
Clinical stage at the time of sur-
gery (TNM classification)
T1: 0 (0.0%); T2: 2(4.4%); T3: 41 
(93.2%); T4: 2(4.4%)
M0: 45 (100%)
N0: 15 (33.3%) N1: 17 (37.8%) N2: 13 
(28.9%)
T1: 0 (0.0%); T2: 0 (0.0%)
T3: 44 (100.0%); T4: 0 (0.0%)
M0: 44 (100%)
N0: 28 (63.6%), N1: 14 (31.8%), N2: 2 
(4.5%)
*p = 0.002 for N feature





Adjuvant treatment Treated: 26 (47.8%)
Not treated: 19 (42.2%)
Treated: 24 (54.6%)
Not treated: 20 (45.4%)
p = 0.17
Histological malignancy grading G1: 1 (2.2%). G2: 34 (75.6%). G3: 10 
(22.2%)
G1: 3 (6.8%). G2: 33 (75.0%). G3: 8 
(18.2%)
p = 0.54
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1—weak, 2—moderate, 3—intense. The intensity of infil-
tration was assessed in the areas with the highest presence 
of infiltration (hotspots), separately within the tumor and in 
the infiltrating front of the tumor.
Due to the low number of positive cells, the presence 
of  iNOS+ was determined under 40× magnification in the 
areas corresponding to the most intensified infiltration of 
 CD68+.
In the case of  CD8+ lymphocytes, their absolute num-
ber in the tumor stroma was counted within one high 
power field (hpf) under 40× magnification (hpf diam-
eter of the optical track of the microscope was 22 mm). 
Only the fields with the highest intensity of infiltration 
within the tumor stroma were selected for the assessment. 
A similar methodology was applied to  FoxP3+ lympho-
cytes, choosing the areas in the consecutive serial par-
affin-embedded section that analogically corresponded 
to the areas selected at the time of  CD8+ lymphocyte 
counting. In rare cases when the number of  FoxP3+ lym-
phocytes was higher than the number of  CD8+ cells, 
the higher value was adopted for both parameters. The 
adopted methodology constitutes a simplified method of 
the assessment of the intensity of  CD8+/FoxP3+ infiltra-
tion based on the phenotype averaged for the entire area 
Table 2  The summary of the most significant technical details related to immunohistochemical staining






iNOS Novus Biologicals, UK Polyclonal Antibody Diluent with Background 
Reducing Components Dako, 
Denmark
1:300 30 Appendix
FoxP3 Zytomed Systems, Germany Monoclonal SP97 EnVisionTMFLEX Antibody Diluent 
Dako, Denmark
1:150 30 Tonsil
CD8 Dako, Denmark Monoclonal C8/144B EnVisionTMFLEX Antibody Diluent 
Dako, Denmark
1:1 20 Tonsil
CD68 Dako, Denmark Monoclonal PG-M1 EnVisionTMFLEX Antibody Diluent 
Dako, Denmark
1:100 20 Tonsil
Fig. 1  The results of CD8 
positive control—tonsil (a), 
CD68—tonsil (b), FoxP3—ton-
sil (c), iNOS—appendix (d)
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and it definitely does not allow identification of separate 
lymphocytes as  CD8+/FoxP3+.
Ethical Consideration
This study was conducted in accordance with the guide-
lines of the Declaration of Helsinki and its subsequent 
amendments, and informed consent was obtained from all 
patients.
Statistical Analysis of the Results
Statistical analysis of the results was performed using 
Statistica v. 8.0 PL, Stat Soft Poland. The comparisons 
of the mean values of the analyzed parameters were per-
formed using the nonparametric Mann–Whitney U test for 
the variables in the ordinal scale or the Student’s t test for 
variables in the interval scale. Normal distribution of the 
analysed values was verified using the Shapiro–Wilk test. 
The comparisons of DFS and OS of patients depending on 
the analysed factors were performed using the log-rank test 
whereas their graphic representation was prepared using 
the Kaplan–Meier method. The p = 0.05 level of signifi-
cance was adopted for all statistical tests.
Results
The Results of the Evaluation of the Intensity 
and the Character of Macrophage Infiltration
Patients in whom recurrence was observed at the follow-
up presented much more frequently with massive M2 
macrophage infiltration  CD68+/iNOS− see assumptions 
described in “Material and Methods”. Their intensity 
within the connective tissue matrix of the tumor was clas-
sified in the overwhelming majority as moderate (2+) or 
intense (3+), with almost no infiltration intensity graded 
as (0) and (1+). These differences were highly statistically 
significant (p = 0.008).
Intense infiltration of M2 macrophages within the tumor 
stroma was related to shorter DFS (727 vs. 1397 days) and 
shorter OS (891 vs. 1411 days) with the levels of signifi-
cance at p = 0.005 and p = 0.006, respectively. The relative 
risks of recurrence and cancer-related death were almost 
twice higher in the group of patients with intense infiltra-
tion of M2 macrophages within the tumor as compared to 
patients with no infiltration. The coefficients of the rela-
tive risks of recurrence and cancer-related death were RR 
2.05, 95% CI 1.33–3.14, p = 0.001 and RR 2.08, 95% CI 
1.28–3.39, p = 0.003, respectively.
Survival curves for DFS and OS in the compared groups 
of patients are presented in Fig. 2, whereas representative 
examples of M2 macrophage infiltration of various inten-
sity are presented in Fig. 3a, c.
The multifactorial analysis included three variables of 
potential prognostic value, i.e. the N feature of the TNM 
Classification of Malignant Tumours (TNM) classification, 
infiltration intensity of M2 macrophages and  CD8+/FoxP3+ 
(Treg) lymphocytes within the tumor stroma. The analysis 
did not confirm the role of intensity of M2 infiltration as an 
independent prognostic factor both in relation to DFS and 
OS. However, a positive correlation of moderate intensity 
was confirmed between the intensity of infiltration of Treg 
lymphocytes and M2 within the tumor stroma (R = 0.54, 
p < 0.0001; Spearman rank correlation test).
In the case of M2 macrophage infiltration in the tumor 
front, an opposite tendency was observed, i.e. intense 
Fig. 2  The Kaplan–Meier’s survival curves depending on the intensity of the infiltration of the tumor stroma by M2 macrophages for DFS (a) 
and OS (b). Sample size: TAM 0–1 n = 15; TAM 2–3 n = 74
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infiltration of TAMs at the tumor edge and the surround-
ing tissues was related to a lower recurrence rate. How-
ever, this relationship did not reach statistical significance 
(p = 0.061).
The Results of the Assessment of the Number 
of Infiltrating T Lymphocytes
Details concerning intensity of immune cells infiltrates 
over particular clinico-histopathological categories are 
shown in Table 3.
The infiltration of T lymphocytes showing the expres-
sion of  CD8+ surface antigens was observed both in the 
connective tissue of the tumor stroma and in malignant 
cells.
In patients with recurrence at the follow-up, more 
intense  CD8+ lymphocyte infiltration was observed with 
concurrent higher relative participation of  CD8+/FoxP3+ 
(Treg) lymphocytes in the pool of  CD8+, which was 
expressed by a higher number of Treg lymphocytes/hpf 
compared to the patients with no recurrence. These differ-
ences were highly statistically significant (p < 0.0001; see 
Tables 4, 5; Figs. 3a, d, 4).
The presence of >11  FoxP3+ lymphocytes/hpf in the 
tumor stroma was related to an unfavorable prognosis 
regarding both DFS and OS (p < 0.0001, log-rank test). 
Intense  FoxP3+ infiltration correlated with shorter DFS 
(463 vs. 1193  days) in the group with a lower number 
of  FoxP3+ lymphocytes in the tumor stroma. Similarly, 
the mean time to death due to cancer in the group with 
the number of Treg lymphocytes above the median was 
682 days as compared to 1256 days in the group with the 
number of Treg lymphocytes below the median.
Relative risk of recurrence in the group of patients with 
intense Treg infiltration was more than 12 times higher 
compared to patients with less intense infiltration (RR 12.3, 
95% CI 5.44–27.9, p < 0.0001). Similarly, the risk of can-
cer-related death was significantly higher in this group (RR 
12.5, 95% CI 4.9–32.4, p < 0.0001).
Next to the N feature, the number of Treg lymphocytes/
hpf remained an independent prognostic factor in the Cox’s 
proportional hazards model which included three variables 
of a potential prognostic value, i.e. N feature of the TNM 
classification, intensity of M2 macrophages and  FoxP3+ 
(Treg) lymphocytes. The results of the analysis based on 
the multifactorial model is presented in Table 6.
Discussion
During carcinogenesis, TAMs change their phenotype 
and the manner of interaction with the surroundings, i.e. 
stromal cells, lymphocytes and malignant cells. TAMs, 
which in time polarize toward M2 phenotype with poor 
Fig. 3  Infiltration of  CD68+ 
macrophages (a) and numerous 
 FoxP3+ lymphocytes (b) in the 
tumor stroma in a patient with 
the early systemic neoplastic 
process after surgery. Scant 
 CD68+ and  FoxP3+ infiltrations 
in patient with no symptoms of 
the disease at the time of the 
follow-up (c and d, respec-
tively). Original magnification: 
×200 (a–c); ×400 (d)
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antigen-presenting capability and immunosuppressive 
activity by releasing immunosuppressive factors (IL-10, 
TGF-β, EGF, VEGF, MMPs), are regarded to be pro-
tumor for many cells (Kryczek et  al. 2006). However, 
despite the fact that M2 TAMs play adverse role related 
to a poorer prognosis for the majority of tumors (Chai 
et  al. 2008; Kryczek et  al. 2006; Tsutsui et  al. 2005), in 
the case of CRC it is not so evident. Some authors report 
that high density of TAMs is associated with an unfavora-
ble prognosis (Cui et  al. 2013; Tan et  al. 2005), whereas 
other reports demonstrate contrary results (Algars et  al. 
2012; Gulubova et al. 2013; Forssell et al. 2007; Zhou et al. 
Table 3  Descriptive statistics 
over clinico-histopathological 
categories
P statistical significance level of *t test and +ANOVA test (significant differences marked with bold font); 
CD8+ number of CD8-positive cells per high power field (hpf) of view, FoxP3+ number of FoxP3-positive 
cells per hpf, FoxP3/CD8 fraction of FoxP3-positive cells in the pool of CD8-positive cells, TAM intensity 
of CD68-positive cells infiltrates in the tumor tissue
Feature CD8+ (1/hpf) FoxP3+ (1/hpf) FoxP3/CD8 (%) TAM
Age
 <median n = 43 (48.3%) 28.3 (14.0) 13.8 (11.9) 44.3 (25.0) 0:2; 1:6; 2:25; 3:10
 ≥median n = 46 (51.7%) 34.1 (19.6) 16.0 (12.5) 45.8 (24.8) 0:2; 1:5; 2:23; 3:16
Gender
 F: n = 44 (49.4%) 35.5 (19.1)*
p = 0.03
16.5 (13.0) 43.4 (22.9) 0:2; 1:4; 2:22; 3:16
 M: n = 45 (50.6%) 27.4 (14.6) 13.5 (11.3) 46.7 (26.6) 0:2; 1:8; 2:25; 3:10
Clinical stage at the time of surgery (T status)
 T1: n = 0 (0%) – – – –
 T2: n = 2 (2.2%) 44.5 (21.9) 33.5 (20.5)+
p = 0.03
72.6 (10.2) 0:0; 1:0; 2:1; 3:1
 T3: n = 85 (95.6%) 30.6 (17.1) 14.2 (11.7) 44.0 (24.7) 0:4; 1:1l; 2:46; 3:24
 T4: n = 2 (2.2%) 46.5 (16.3) 27.5 (0.71) 63.3 (23.7) 0:0; 1:0; 2:1; 3:1
Clinical stage at the time of surgery (N status)






0:3; 1:6; 2:25; 3:9
 N1: n = 31 (34.8%) 34.6 (19.8) 16.1 (12.7) 44.0 (24.3) 0:1; 1:2; 2:16; 3:12
 N2: n = 15 (16.9%) 37.6 (17.6) 24.4 (13.0) 65.1 (22.5) 0:0; 1:3; 2:7; 3:5
Clinical stage






0:3; 1:6; 2:25; 3:9
 III: n = 46 (51.7%) 35.6 (18.9) 18.8 (13.3) 50.9 (25.5) 0:1; 1:5; 2:23; 3:17
Histological malignancy grading
 G1: n = 4 (4.4%) 40.5 (18.3) 14.3 (9.9) 38.3 (23.9) 0:0; 1:0; 2:3; 3:1
 G2: n = 67 (75.3%) 29.1 (16.3) 14.1 (11.9) 44.8 (24.4) 0:3; 1:9; 2:38; 3:17
 G3: n = 18 (20.3%) 37.5 (19.4) 18.3 (13.6) 47.7 (27.4) 0:1; 1:1; 2:7; 3:8
Table 4  The summary of the results of tumor infiltration by lymphocytes and tumor associated macrophages in correlation to the occurrence of 
recurrences
Feature Patients with recurrence n = 44 Patients with no recur-




The number of (cytotoxic)  CD8+ T lymphocytes/hpf Mean 38.4, SD 15.7 Mean 24.1, SD 15.9 p < 0.0001
The number of T regulatory  FoxP3+/hpf Mean 23.6, SD 11.3 Mean 6.1, SD 3.9 p < 0.0001
Participation of  FoxP3+ lymphocytes in the pool of  CD8+ 
lymphocytes (%)
Mean 61.6, SD 19.5 Mean 28.3, SD 17.2 p < 0.0001
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2010). The results indicating a favorable prognosis related 
to an increase in the density of M2 TAMs were obtained 
from the tumor front and not the tumor itself. It is stressed 
that an improvement in survival is related to high infiltra-
tion by macrophages at the tumor front as an expression of 
a strong immune defense reaction, particularly at the early 
stages of carcinogenesis. Later an increase in the density of 
M2 TAMs in necrotic tumor tissues was observed with the 
concurrent increase in M1 TAMs (Forssell et al. 2007; Shih 
et al. 2006; Tan et al. 2005). The ambiguity of the results 
may be caused by a “variable involvement” of TAMs in 
various locations at various stages of carcinogenesis or a 
different distribution of M2 TAM subpopulation which is 
assayed using four different methods (Shih et  al. 2006). 
Only the outcome of TAM activities results in either pro- 
or anti-tumor influence on inflammation-dependent tumor, 
i.e. CRC. It should be considered that tumor cells are able 
not only to block the activity of TAMs in the tumor, but 
also to modify the activity of TAMs to promote survival 
and progression of the tumor (Shih et  al. 2006). It seems 
that within the tumor front this modulating influence of 
tumor cells is the lowest and the character of TAM activ-
ity in this area is anti-tumor. Within the tumor, especially 
in more advanced stages, the outcome of the microenviron-
ment activity on TAMs is pro-tumor.
In our study, in CRC patients with stages IIA, IIIB, 
and IIIC, a high density of  iNOS− TAMs in the tumor 
itself is related to shorter survival time and a high risk of 
Table 5  The summary of the results of tumor infiltration by lymphocytes and tumor associated macrophages in correlation to the disease-related 
deaths
Feature Patients died of disease, n = 51 Alive patients, n = 38 Level of statis-
tical signifi-
cance
The number of (cytotoxic)  CD8+ T lymphocytes/hpf Mean 39.1, SD 16.3 Mean 25.5, SD 15.7 p < 0.0002
The number of T regulatory  FoxP3+/hpf Mean 24.0, SD 10.9 Mean 8.1, SD 7.9 p < 0.0001
Participation of  FoxP3+ lymphocytes in the pool of  CD8+ 
lymphocytes (%)
Mean 62.9, SD 18.4 Mean 31.9, SD 20.3 p < 0.0001
Distribution of TAM infiltration intensities 0:4 (4.5%) 0:0 (0.0%) p < 0.002
1:9 (10.1%) 1:2 (2.2%)
2:27 (30.3%) 2:21 (23.6%)
3:11 (12.4%) 3:15 (16.9%)
Fig. 4  The Kaplan–Meier’s survival curves depending on the intensity of the infiltration of the tumor stroma by  FoxP3+ Tregs for DFS (a) and 
OS (b)
Table 6  The results of the Cox multifactorial risk model
RR relative risk, 95% CI 95% confidence interval
Feature RR Standard error Statistical 
significance, 
p
95% CI of RR
N 1.5 0.19 0.027 1.1–2.2
FoxP3+ <11 10.8 0.42 0.0001 4.7–24.7
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recurrence, which is consistent with the reports of Cui et al. 
(2013) and Tan et al. (2005). However, it significantly cor-
relates with the number of Treg lymphocytes within the 
tumor stroma and thus it does not constitute an independ-
ent prognostic factor. Furthermore, this relationship may 
be an indirect evidence of the TAM role in programming 
the immunomodulatory function of  FoxP3+ lymphocytes 
within the tumor stroma, which is also reported by other 
authors (Gabrilovich et al. 2012; Galon et al. 2006; Ram-
anathan et  al. 2008). However, an opposite tendency was 
observed within the tumor front, i.e. an increase in the 
intensity of  iNOS− TAMs infiltration in the tumor front was 
related to a better prognosis. This relationship, however, 
did not reach statistical significance (p = 0.061).
In the present study, the method of an indirect assess-
ment of M2 macrophage infiltration by subtracting the 
number of M1  iNOS+ macrophages from the pool of all 
 CD68+ macrophages infiltrating the tumor was intended to 
identify the M2 subtype with consideration given to a num-
ber of subtypes characterized by diverse expression profiles 
of specific markers. The lack of the possibility to confirm a 
simultaneous expression of markers in specific single cells 
in the case of  CD68+/iNOS− as well as  CD+/FoxP3+ phe-
notypes constitutes a limitation of the adopted methodol-
ogy. However, it could be overcome by the evaluation of 
immunohistochemistry reactions in the corresponding areas 
on the serial histological sections. It seems that this simpli-
fication does not affect the prognostic value for such deter-
mination of M2 TAMs and Treg lymphocytes. Certainly, 
the use of combination of single-specific markers for M2 
TAMs in the same section would eliminate the omission of 
a small number of macrophages in this subpopulation but it 
would render the in  situ determination technically impos-
sible and it would increase the costs and, consequently, 
the availability of the test. We are of the opinion that not 
covering of all M2 phenotypes should not have a signifi-
cant influence on its practical usefulness and the intensity 
of  CD68+/iNOS− macrophage infiltration within the tumor 
stroma seems to be a good prognostic factor in CRC.
The  FoxP3+ transcription factor, which plays a sig-
nificant role in the regulation of the development and the 
activity of the immune system, is treated as an immunosup-
pressive factor. It is considered the most specific marker 
for  CD4+/CD25+ and  CD8+/CD25+ Treg lymphocytes, 
although its expression was also confirmed in tumor cells 
(Chaput et al. 2009; Takenaka et al. 2013). The majority of 
studies investigate the subpopulation of Treg cells showing 
the expression of  CD4+/CD25+ and the knowledge related 
to them is broader. A high density of  FoxP3+ Treg cells 
infiltrating the tumor stroma is considered a poor prog-
nostic factor in numerous types of tumor (Gao et al. 2007; 
Hiraoka et  al. 2006; Kobayashi et  al. 2007; Merlo et  al. 
2009; Sasada et  al. 2003; Xue et  al. 2010). However, the 
study results on CRC are ambiguous (Ling et al. 2007; Lod-
denkemper et al. 2006; Salama et al. 2009). Some authors 
recognize FoxP3+ Tregs as an unfavorable prognostic fac-
tor (Grimmig et al. 2013; Michel et al. 2008), whereas oth-
ers confirm that a high density of Tregs is related to a good 
prognosis (Ladoire et  al. 2011). Another group of studies 
negates its value (Chaput et al. 2009; Loddenkemper et al. 
2006), whereas Kim et al. (2013) are of the opinion that it 
is high expression of  FoxP3+ in tumor cells and not in Treg 
lymphocytes that is related to a bad prognosis as compared 
to patients with low  FoxP3+ expression.
The results of our study on  CD8+/FoxP3+ lymphocytes 
indicate that the increase in the intensity of the infiltration 
of the tumor stroma by such defined subpopulation of Treg 
cells may be considered an unfavorable and independent 
prognostic factor. This may be attributable to their suppres-
sive influence on anti-tumor activity of the immune sys-
tem and may be the result of a subtle regulation occurring 
between lymphocytes related to  CD8+/FoxP3+ tumor and 
macrophages related to  CD68+/iNOS− tumor whose co-
location in the tumor stroma was confirmed in the present 
study.
As in the case of macrophage determination, it should 
be considered that the applied single staining method of the 
corresponding areas in serial sections renders the identifi-
cation of individual lymphocytes as  CD8+/FoxP3+ impos-
sible and it merely allows an overall assessment of these 
areas from a statistical perspective.
In conclusion, our retrospective study comprising 89 
CRC patients with stages IIA, IIIB, and IIIC confirms that 
infiltration of the tumor stroma by  CD68+/iNOS− TAMs 
and  CD8+/FoxP3+ Tregs is a negative prognostic factor 
and there is a positive correlation between these types of 
infiltration.
The intensity of the infiltration of the tumor stroma by 
 CD8+/FoxP3+ lymphocytes may constitute an independent 
prognostic factor in the group of CRS patients with stages 
IIA, IIIB, and IIIC, which requires confirmation in prospec-
tive studies.
The proposed methodology of TAM and Treg phenotype 
identification in histological sections is mainly directed at 
practical use in routine clinical management.
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